The development of new inhibitors targeting the KasA enzyme in Mycobacterium tuberculosis presents significant potential in combating tuberculosis (TB). Researchers have applied machine learning techniques combined with free energy methods to identify novel compounds that inhibit KasA, an enzyme critical to the survival and virulence of the TB bacterium. This innovative approach leverages…
